by Mizzima News
Sunday, 05 April 2009 23:34
Rangoon (Mizzima) – The Burmese military junta has banned the production and distribution of two Burmese indigenous medicines because of its lead and arsenic content.
The medicines have been identified as Daw Htwe’s ‘Gawmotta’ and Daw Kyin’s, meant for children.
After US health officials found lead and arsenic poisoning among Burmese children, the Ministry of Health in Burma banned the production and distribution of these two medicines.
Recently both the medicine producers were given official permission for production for another three years by the Burmese Indigenous Medicine Department and Medical Research.
We submitted our samples in November 2008. They instructed us not to use two ingredients the ‘Saydan’ (Arsenious Trisulphide) and sulphur in the medicines. So we excluded these two ingredients and continued production with official permission and license which is valid for three years till 2011,” an official of the Monywa Gawmotta factory said.
Continue reading “The Burmese military junta has banned the production and distribution of two Burmese indigenous medicines because of its lead and arsenic content.”